Vaccine News and Research

Latest Vaccine News and Research

Researchers dispel myths on increased incidence of autism disorder

There has been a major increase in the number of children diagnosed with autistic spectrum disorders over the last two decades - the question is why? Researchers have found a sharp difference between the beliefs of ordinary people and medical experts about the reasons for the increased incidence of autism.

10 Dec 2009

Study reveals increased discussion on flu vaccines has no significant impact on public's behavior

Seasonal flu vaccination rates among American adults have only slightly improved over last year, despite increased public discussion of the importance of influenza vaccines resulting from the worldwide outbreak of the H1N1 virus.

10 Dec 2009

NIH awards Lentigen a SBIR grant for program to generate Hepatitis C Virus-Like Particles

Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today that it has received a National Institutes of Health (NIH) small business innovation research (SBIR) grant for a program on "A Novel Method of Generating Hepatitis C Virus-Like Particles using Lentivirus". In this program, Lentigen will collaborate with Epixis SA (Paris, France).

9 Dec 2009

Alternative, fast and safe process for producing large quantities of effective flu vaccines

A shortage of flu vaccines may soon become a problem of the past. Researcher Manon Cox has developed an alternative process for producing large quantities of safe and effective vaccines at twice to four times the usual speed. The process is based on using cells in bioreactors instead of fertilised chicken's eggs, which have a limited availability.

9 Dec 2009

Human blood stem cells can be engineered to kill HIV and other chronic viral diseases

Researchers from the UCLA AIDS Institute and colleagues have for the first time demonstrated that human blood stem cells can be engineered into cells that can target and kill HIV-infected cells - a process that potentially could be used against a range of chronic viral diseases.

9 Dec 2009

Breakthrough findings may lead to new treatments for Ebola hemorrhagic fever

Scientists at The Scripps Research Institute have determined the structure of a critical protein from the Ebola virus, which, though rare, is one of the deadliest viruses on the planet killing between 50 and 90 percent of those infected.

9 Dec 2009

Statewide blood screening program identifies infants with T-cell lymphopenia

The testing of DNA from a statewide blood screening program for newborns in Wisconsin was able to identify infants with T-cell lymphopenia, a blood disorder that affects the child's immune system, a disease in which early identification is important, according to a study in the December 9 issue of JAMA.

9 Dec 2009

Physicians trust the safety and efficacy of H1N1 vaccine

A recent visit to the pediatric H1N1 vaccine clinic at a major Chicago medical center showed a surprising clientele - most parents bringing their children for vaccination were also medical professionals.

9 Dec 2009

Researchers find striking disparities in HPV vaccine awareness among low-income population

Results of two separate studies show lower rates of HPV vaccination in low-income populations, and identify vaccination barriers and tailored interventions that may help to increase HPV vaccine uptake rates.

9 Dec 2009

Immune-boosting drug: A new way for improving cancer treatment

Stimulating the body's own immune system to fight cancer offers new treatment opportunities for cancer patients, and scientists have made the first step towards finding existing drugs that could help.

9 Dec 2009

Macomb County Health Department opens new H1N1 influenza immunization clinics

Sfter holding more than a dozen H1N1 influenza immunization clinics this fall targeting people in high-risk groups, the Macomb County Health Department announced today that it is opening its upcoming clinics to everyone 6 months of age and older.

9 Dec 2009

Reuters news examines quest for new TB drugs, vaccines

Reuters examines the search for new tuberculosis medicines and vaccines. "Although TB has plagued humankind for thousands of years, there is only one vaccine," which isn't very effective and doesn't protect adults. "With the exception of rifabutin, there has been no new drug for TB for more than 40 years," the news service writes.

8 Dec 2009

Also in Global Health news: Rotavirus vaccine; guinea worm eradication; health systems; Zulu King calls for male circumcision

The West African Rotavirus Advisory Board is calling on governments to vaccinate children against rotavirus, IRIN reports. At a recent meeting in Dakar, Senegal, which was "financed by GlaxoSmithKline, makers of one of two rotavirus vaccines" the board issued a document recommending that governments "immediately recognize the magnitude of the rotavirus problem and make vaccination against the virus a priority" (12/8).

8 Dec 2009

Swine flu news round-up

The German government is looking to sell over 2 million leftover doses of the H1N1 (swine flu) vaccine, the country's health minister said Monday, Agence France-Presse reports. "A health ministry senior official in the state of Thuringia, Hartmut Schubert, said that the vaccines could even be donated and that there had been requests from Afghanistan and Eastern European countries including Ukraine," the news service adds (12/7).

8 Dec 2009

ADVocacy for IMmunization program receives a three-year grant from the Bill & Melinda Gates Foundation

The Agence de Médecine Préventive (AMP) has received a three-year grant from the Bill & Melinda Gates Foundation to implement a program to support immunization advocacy in West Africa.

8 Dec 2009

Interim data from Geron's GRNVAC1 phase II trial for AML presented

Geron Corporation today announced the presentation of interim data from its phase II trial of GRNVAC1, an autologous dendritic cell vaccine targeting telomerase, in patients with acute myelogenous leukemia (AML) at the 51st Annual Meeting of the American Society of Hematology (ASH) in New Orleans, Louisiana.

8 Dec 2009

BARDA cancels PharmAthene's RFP for Recombinant Protective Antigen Anthrax Vaccine

PharmAthene, Inc. a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that the Department of Health and Human Services Biomedical Research and Development Authority (BARDA) has canceled its request for proposal (RFP) for Recombinant Protective Antigen Anthrax Vaccine for the Strategic National Stockpile (RFP BARDA 08-15).

8 Dec 2009

Department of Health reminds at-risk Pennsylvanians to receive H1N1 vaccination

The federal Centers for Disease Control and Prevention, or CDC, has allocated a total of 2,940,300 doses of H1N1 flu vaccine to Pennsylvania to date, the state Department of Health said today.

8 Dec 2009

Enrollment of patients for Phase I/IIa clinical study of Interleukin-7 commenced

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in its Phase I/IIa clinical program evaluating the company’s investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in combination with standard antiviral treatment and vaccination in HBeAg-negative chronic hepatitis B-infected (HBV) patients.

8 Dec 2009

LCA-GA praises Senators' support in establishing comprehensive program for lung cancer

Today, Lung Cancer Alliance-Georgia (LCA-GA) acknowledged Senators Saxby Chambliss (R-GA) and Johnny Isakson (R-GA) for their leadership and support in establishing the first ever multi-agency, comprehensive program targeted at lung cancer.

8 Dec 2009

Vaccine News and Research

Latest Vaccine News and Research

Researchers dispel myths on increased incidence of autism disorder

Study reveals increased discussion on flu vaccines has no significant impact on public's behavior

NIH awards Lentigen a SBIR grant for program to generate Hepatitis C Virus-Like Particles

Alternative, fast and safe process for producing large quantities of effective flu vaccines

Human blood stem cells can be engineered to kill HIV and other chronic viral diseases

Breakthrough findings may lead to new treatments for Ebola hemorrhagic fever

Statewide blood screening program identifies infants with T-cell lymphopenia

Physicians trust the safety and efficacy of H1N1 vaccine

Researchers find striking disparities in HPV vaccine awareness among low-income population

Immune-boosting drug: A new way for improving cancer treatment

Macomb County Health Department opens new H1N1 influenza immunization clinics

Reuters news examines quest for new TB drugs, vaccines

Also in Global Health news: Rotavirus vaccine; guinea worm eradication; health systems; Zulu King calls for male circumcision

Swine flu news round-up

ADVocacy for IMmunization program receives a three-year grant from the Bill & Melinda Gates Foundation

Interim data from Geron's GRNVAC1 phase II trial for AML presented

BARDA cancels PharmAthene's RFP for Recombinant Protective Antigen Anthrax Vaccine

Department of Health reminds at-risk Pennsylvanians to receive H1N1 vaccination

Enrollment of patients for Phase I/IIa clinical study of Interleukin-7 commenced

LCA-GA praises Senators' support in establishing comprehensive program for lung cancer

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Vaccine News and Research

Latest Vaccine News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in